
Real World Evidence Solutions Market Demand, Share, Future Trends And Business Opportunity 2027
Global Real World Evidence Solutions Market by Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Neurology), End User (Pharma & Medtech, Payers, Providers) - Global Forecast to 2027
Published: Oct-2021 | Report ID: MEDE2111 | Pages: 1 - 215 | Formats*: |
Category : Medical Devices |
- IQVIA (US)
- IBM (US)
- ICON plc. (Ireland)
- PAREXEL International Corporation (US)
- PPD, LLC (US)
- Optum Inc. (US)
- Cognizant (US)
- Oracle (US)
- SAS (US)
- Syneos (US)
- Anthem (US)
- Clinigen (UK)
- PerkinElmer (US)
- Cerner Corporation (US)
- Medpace (US)
- Aetion (US)
- Cegedim Health Data (France)
- TriNetX (US)
- Trinity (US)
- Verantos (US)
- Sciformix (US)
- Ciox Health (US)
- Tempus (US)
- Flatiron Health (US)
- And Syapse (US)
4.1. Introduction4.2. Market Dynamics
4.2.1. Drivers4.2.2. Restraints4.2.3. Opportunities4.2.4. Challenges
4.3. COVID-19 Impact of the RWE solutions Market
5.1. Introduction5.2. Industry Trends
6.1. Services6.2. Data sets
6.2.1. Clinical setting data6.2.2. Claims data6.2.3. Pharmacy data6.2.4. Patient powered data
7.1. Oncology7.2. Cardiovascular7.3. Neurology7.4. Immunology7.5. Others
8.1. Pharmaceutical & Medical devices companies8.2. Healthcare providers8.3. Healthcare payers8.4. Other End Users
9.1. North America
9.1.1. US9.1.2. Canada
9.2. Europe
9.2.1. Germany9.2.2. UK9.2.3. France9.2.4. Italy9.2.5. Spain9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China9.3.2. Japan9.3.3. India9.3.4. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Latin America9.4.2. Middle East & Africa
10.1. Introduction10.2. Market Ranking Analysis, By Key Players (2020)10.3. Competitive Situation and Trends
10.3.1. Product Launches10.3.2. Partnerships, Collaborations and Agreements10.3.3. Acquisitions10.3.4. Expansions10.3.5. Other Developments
11.1. IQVIA (US)11.2. IBM (US)11.3. ICON, plc. (Ireland)11.4. PAREXEL International Corporation (US)11.5. PPD, LLC (US)11.6. Optum, Inc. (US)11.7. Cognizant (US)11.8. Oracle (US)11.9. SAS (US)11.10. Syneos (US)11.11. Anthem (US)11.12. Clinigen (UK)11.13. PerkinElmer (US)11.14. Cerner Corporation (US)11.15. Medpace (US)11.16. Aetion (US)11.17. Cegedim Health Data (France)11.18. TriNetX (US)11.19. Trinity (US)11.20. Verantos (US)11.21. Sciformix (US)11.22. Ciox Health (US)11.23. Tempus (US)11.24. Flatiron Health (US)11.25. Syapse (US)
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment






Related Reports
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.